Tevogen Bio Holdings Inc. (TVGN)
NASDAQ·Healthcare·Biotechnology
$6.64
-5.14%
Mkt Cap $31.33M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 31, 2026 | — | — | — | -$1.50 | -$1.50 | +0.00% | — | — |
| Q4 2025 Nov 14, 2025 | — | — | — | -$0.06 | -$0.03 | +50.66% | — | — |
| Q3 2025 Aug 19, 2025 | — | — | — | -$0.05 | -$0.03 | +40.00% | — | — |
| Q2 2025 May 14, 2025 | — | — | — | -$0.05 | -$3.21 | -6494.37% | — | — |
| Q2 2025 Apr 2, 2025 | — | — | — | -$0.03 | -$2.60 | -7542.35% | — | — |
| Q4 2024 Nov 19, 2024 | — | — | — | — | -$1.74 | — | — | — |
| Q3 2024 Aug 14, 2024 | — | — | — | — | -$1.96 | — | — | — |
| Q2 2024 May 27, 2024 | — | — | — | — | $3.96 | — | — | — |
| Q4 2023 Dec 31, 2023 | — | — | — | — | -$1.12 | — | — | — |
| Q3 2023 Sep 30, 2023 | — | — | — | — | -$1.23 | — | — | — |
| Q2 2023 Jun 30, 2023 | — | — | — | — | -$7.98 | — | — | — |
| Q1 2023 Mar 31, 2023 | — | — | — | — | -$12.82 | — | — | — |
| Q4 2022 Dec 31, 2022 | — | — | — | — | $2.73 | — | — | — |
| Q3 2022 Sep 30, 2022 | — | — | — | — | $1.68 | — | — | — |
| Q2 2022 Jun 30, 2022 | — | — | — | — | $0.22 | — | — | — |
| Q1 2022 Mar 31, 2022 | — | — | — | — | -$0.03 | — | — | — |
| Q4 2021 Dec 31, 2021 | — | — | — | — | -$0.02 | — | — | — |
| Q3 2021 Sep 30, 2021 | — | — | — | — | -$0.00 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | — | — | — | -$0.01 | — | — | — |